Epstein Secrets

tive President and CEO Linda Goler Blount; Kids v. Cancer founder and Executive Director Nancy Goodman; Harvard Medical School Professor of Medicine Aaron Seth Kesselheim; National Bone Marrow Donor Program Chief Legal Officer and General Counsel Brian Lindberg; and U.S. Anti-Doping Agency CEO Travis Tygart; 10:00 AM

nure of service as U.S. Representative to the Organization for the Prohibition of Chemical Weapons; Jenny McGee to be USAID Associate Administrator; Richard Mills Jr. to be the U.S. Deputy Representative to the United Nations, with the rank and status of ambassador, and U.S. Deputy Representative in the United Na

ive President and CEO Linda Goler Blount; Kids v. Cancer founder and Executive Director Nancy Goodman; Harvard Medical School Professor of Medicine Aaron Seth Kesselheim; National Bone Marrow Donor Program Chief Legal Officer and General Counsel Brian Lindberg; and U.S. Anti-Doping Agency CEO Travis Tygart; 10:00 AM

ure of service as U.S. Representative to the Organization for the Prohibition of Chemical Weapons; Jenny McGee to be USAID Associate Administrator; Richard Mills Jr. to be the U.S. Deputy Representative to the United Nations, with the rank and status of ambassador, and U.S. Deputy Representative in the United Na

ive President and CEO Linda Goler Blount; Kids v. Cancer founder and Executive Director Nancy Goodman; Harvard Medical School Professor of Medicine Aaron Seth Kesselheim; National Bone Marrow Donor Program Chief Legal Officer and General Counsel Brian Lindberg; and U.S. Anti-Doping Agency CEO Travis Tygart; 10:00 AM

ure of service as U.S. Representative to the Organization for the Prohibition of Chemical Weapons; Jenny McGee to be USAID Associate Administrator; Richard Mills Jr. to be the U.S. Deputy Representative to the United Nations, with the rank and status of ambassador, and U.S. Deputy Representative in the United Na